Clinton Proposes $1.15 Billion Increase For NIH; Support For Cancer Research
In Brief: Breast Cancer Cells To Be Studied In Space; GrieshaberTo Head Drug Discovery Program
Advocacy. Bypass Budget Treated As Serious Funding Request By Advocates
Medicare Coverage For Clinical Trials Tops NBCC Agenda
Gore, Agency Report, Support Legislation To Protect Genetic Info
Regulatory Agencies: FDA To Increase Fees For Mammography Facility Inspections
Clarification: Full Text Of ACS Guideline On Prostate Screening
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”
Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs
